A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/01/2011	US8049016 Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymes
11/01/2011	US8049015 Heteroaryl antagonists of prostaglandin D2 receptors
11/01/2011	US8049014 Aminoquinoline derivatives, preparation method thereof and pharmaceutical composition comprising the same
11/01/2011	US8049012 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
11/01/2011	US8049008 Reverse-turn mimetics and method relating thereto
11/01/2011	US8049005 Substituted tetrahydropyrazolo-pyrido-azepine compounds
11/01/2011	US8049003 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
11/01/2011	US8048998 Mediated cellular delivery of LNA oligonucleotides
11/01/2011	US8048997 Process for drying uronic acid oligosaccharides
11/01/2011	US8048996 Molecular transporters based on sugar and its analogues and processes for the preparation thereof
11/01/2011	US8048928 Therapeutic agent for treating liver disease containing 2-amino-1,3-propanediol derivative as active ingredient, and method for treating liver disease
11/01/2011	US8048927 Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
11/01/2011	US8048926 L-DOPA amide derivatives and uses thereof
11/01/2011	US8048925 Bis(thio-hydrazide amide) salts for treatment of cancers
11/01/2011	US8048924 Methods and compositions employing 4-aminophenylacetic acid compounds
11/01/2011	US8048923 Treatment of polyglutamine disorders caused by expanding genomic CAG nucleotides
11/01/2011	US8048922 Compositions and methods for treating feline inflammatory bowel disease
11/01/2011	US8048921 Amino acid compounds
11/01/2011	US8048920 Personal care composition containing bio-derived 1,3-propanediol and its conjugate esters
11/01/2011	US8048919 Use of ethyl lactate as an excipient for pharmaceutical compositions
11/01/2011	US8048918 Treatment of hyperproliferative diseases
11/01/2011	US8048917 Prodrugs of GABA analogs, compositions and uses thereof
11/01/2011	US8048915 Biologically active complex
11/01/2011	US8048914 Methods for isolation of triptolide compounds from Tripterygium wilfordii
11/01/2011	US8048913 Compositions and products containing S-equol, and methods for their making
11/01/2011	US8048912 Benzopyran derivatives having inhibitory activities against liver fibrosis and cirrhosis and their pharmaceutical uses
11/01/2011	US8048911 Melanin eliminator preparation
11/01/2011	US8048910 Combination of R,R-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases
11/01/2011	US8048909 Proton pump inhibitors
11/01/2011	US8048908 11β-hydroxysteroid dehydrogenase type 1 active compounds
11/01/2011	US8048907 Receptor antagonists and their methods of use
11/01/2011	US8048906 Optically pure and enriched isomers of chelating ligands and contrast agents
11/01/2011	US8048905 Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists
11/01/2011	US8048904 Process for the preparation of olmesartan medoxomil
11/01/2011	US8048903 5-iodotetrazoles
11/01/2011	US8048902 Antagonists of lysophosphatidic acid receptors
11/01/2011	US8048901 5-{3-[3-(5-Methyl-2-m-tolyloxazol-4-ylmethoxy)cyclohexyloxy]-propyl}-2H-tetrazole; metabolic disorders, insulin resistance, dyslipidemia, Syndrome X
11/01/2011	US8048900 Use of 15-lipoxygenase inhibitors for treating obesity
11/01/2011	US8048899 Compounds which selectively modulate the CB2 receptor
11/01/2011	US8048898 Inhibitor of binding of S1P1
11/01/2011	US8048897 Cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes
11/01/2011	US8048896 Methods for inhibiting and breaking AGE complex formation
11/01/2011	US8048895 Kappa opioid receptor ligands
11/01/2011	US8048894 Quinolones and azaquinolones that inhibit prolyl hydroxylase
11/01/2011	US8048893 Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them
11/01/2011	US8048892 Azaquinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
11/01/2011	US8048891 Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
11/01/2011	US8048890 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents
11/01/2011	US8048889 3,4-disubstituted coumarin and quinolone compounds
11/01/2011	US8048887 Compounds for the treatment of hepatitis C
11/01/2011	US8048886 Substituted pyrazine-3-one-derivatives as IAP inhibitors
11/01/2011	US8048885 Organic compounds
11/01/2011	US8048884 Substituted piperazinyl pyrazines and pyridines as 5-HT7 receptor antagonists
11/01/2011	US8048883 Chronic Myelogenous Leukemia; crystal form stable at room temperature or higher temperatures up to 120 degrees C. and accelerated stress conditions, freely soluble in water; suspending Imatinib base in isopropanol and adding methane sulfonic acid at room temperature then cooling after reactoion
11/01/2011	US8048882 Pharmaceutical compositions with increased activity
11/01/2011	US8048881 Pyrimidine derivatives and their use as P2Y12 receptor antagonists
11/01/2011	US8048880 Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and SPLA2 inhibitor combination therapies
11/01/2011	US8048879 Substituted 4,5,6,7-tetrahydro-isoxazolo[4,5-c]pyridine compounds and use thereof for producing medicaments
11/01/2011	US8048878 Two cyclic cinnamide compound
11/01/2011	US8048877 Guanidine derivatives and their medical use
11/01/2011	US8048876 Process for preparing quetiapine and quetiapine fumarate
11/01/2011	US8048875 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/01/2011	US8048874 Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
11/01/2011	US8048873 Synergistic pharmaceutical combination for the prevention or treatment of diabetes
11/01/2011	US8048872 Treatment of hyperproliferative diseases with vinca alkaloid N-oxide and analogs
11/01/2011	US8048871 Inhibitors that when coadministered with a drug that undergoes in vivo degradation by cytochrome P450 enzyme, improves the pharmacokinetics, bioavailability and disease treatment such as of HIV, Hepatitis C virus, diabetes, epilepsy, cancer, depression; amide or sulfonamide-functional benzofurans
11/01/2011	US8048870 Apoptosis-inducing antineoplastic silver (I) coordination complexes
11/01/2011	US8048869 Estrogenic component comprising estetrol and estetrol-like substances, which has relatively low estrogenic potency, metabolic stability, long half-life; triene steroids; osteoporosis, arteriosclerosis, cognitive disturbances, Alzheimer's disease, peri- or post-menopausal disorders
11/01/2011	US8048868 Method of preventing preeclampsia
11/01/2011	US8048867 9-substituted minocycline compounds
11/01/2011	US8048866 Preventive and/or therapeutic agent for calcipenia
11/01/2011	US8048865 Method and pharmaceutical to treat spinal discs
11/01/2011	US8048864 Regulators of NFAT and/or store-operated calcium entry
11/01/2011	US8048863 RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions
11/01/2011	US8048862 Macrocyclic inhibitors of hepatitis C virus replication
11/01/2011	US8048861 Pesticidal formulations
11/01/2011	US8048860 Butanol extract of Bidens pilosa
11/01/2011	US8048847 Derivatives of the IL-2 receptor gamma chain, their production and use
11/01/2011	US8048844 Preventing airway mucus production by administration of EGF-R antagonists
11/01/2011	US8048646 NELL peptide expression systems and bone formation activity of NELL peptide
11/01/2011	US8048452 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitor
11/01/2011	US8048451 Microparticles for use in a pharmaceutical composition for pulmonary administration, each microparticle comprising a particle of an active substance having, on its surface, particles of a hydrophobic material suitable for delaying the
11/01/2011	US8048449 Mouth dissolving pharmaceutical composition and process for preparing the same
11/01/2011	US8048442 Modified heparin-based coatings and related drug eluting stents
11/01/2011	US8048441 Nanobead releasing medical devices
11/01/2011	US8048426 Extracts from Chlorella
11/01/2011	US8048408 addition polymerization of zwitterionic monomers, under molecular weight control, to form polymers having low polydispersity, used for drug delivery
11/01/2011	US8048407 In situ gelling self-reactive materials for embolization
11/01/2011	US8048222 Highly pure modafinil
11/01/2011	CA2695167C Methods for the treatment of elevated cholesterol levels
11/01/2011	CA2671949C Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion
11/01/2011	CA2671357C Crystalline form of 1-(.beta.-d-glucopyranosyl)-4-methyl-3-[5-(4-fluorophenyl)-2-thienylmethyl]benzene hemihydrate
11/01/2011	CA2663408C Substituted pyridylmethyl bicyclocarboxyamide compounds
11/01/2011	CA2661759C Buprenophine-wafer for drug substitution therapy
11/01/2011	CA2657550C Benzimidazole derivatives as selective acid pump inhibitors
11/01/2011	CA2653034C Macrocyclic oximyl hepatitis c protease inhibitors
11/01/2011	CA2649521C Novel piperazine compound, and use thereof as hcv polymerase inhibitor
11/01/2011	CA2641473C Condensed imidazole derivatives as aldosterone synthase inhibitors
11/01/2011	CA2640435C Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
11/01/2011	CA2635356C Use of 1,3,5-triazepin-2,6-diones to treat malaria

1 ... 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 ... 7860